143 related articles for article (PubMed ID: 12753751)
1. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
Ikegami K; Tagawa K; Kobayashi M; Osawa T
Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the correlation between in vivo and in vitro release. Effect of the force of contraction and food on drug release.
Aoki S; Ando H; Ishii M; Ida K; Watanabe S; Ozawa H
Biol Pharm Bull; 1994 Feb; 17(2):291-5. PubMed ID: 8205129
[TBL] [Abstract][Full Text] [Related]
3. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
Katori N; Aoyagi N; Terao T
Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
Fukui A; Fujii R; Yonezawa Y; Sunada H
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
[TBL] [Abstract][Full Text] [Related]
5. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
Ikegami K; Tagawa K; Osawa T
J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC).
Ishibashi T; Ikegami K; Kubo H; Kobayashi M; Mizobe M; Yoshino H
J Control Release; 1999 Jun; 59(3):361-76. PubMed ID: 10332066
[TBL] [Abstract][Full Text] [Related]
8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
9. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.
Shameem M; Katori N; Aoyagi N; Kojima S
Pharm Res; 1995 Jul; 12(7):1049-54. PubMed ID: 7494801
[TBL] [Abstract][Full Text] [Related]
10. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
Vashi VI; Meyer MC
J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
[TBL] [Abstract][Full Text] [Related]
11. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
[TBL] [Abstract][Full Text] [Related]
12. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
Chung BH; Shim CK
J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
[TBL] [Abstract][Full Text] [Related]
13. A multi-mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlations.
Liu Y; Schwartz JB; Schnaare RL; Sugita ET
Pharm Dev Technol; 2003; 8(4):409-17. PubMed ID: 14601965
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
15. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
Sevgi F; Ozyazici M; Güneri T
J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
[TBL] [Abstract][Full Text] [Related]
17. Theophylline controlled-release formulations: in vivo-in vitro correlations.
Yu Z; Schwartz JB; Sugita ET
Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
[TBL] [Abstract][Full Text] [Related]
19. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
Hussein Z; Friedman M
Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
[TBL] [Abstract][Full Text] [Related]
20. Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations.
Karasulu E; Apaydin S; Ince I; Tuglular I
Eur J Drug Metab Pharmacokinet; 2006; 31(4):291-8. PubMed ID: 17315541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
